News & Events
Patient Focused Drug Development
Stephanie KallayDirector of Patient Advocacy Partners in Progress: How Patient Insights Drive Innovation At Crinetics, our mission has always been clear: to build the premier endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. But our mission is more than discovery: it’s about delivering real, lasting change for people living with endocrine diseases. We are scientists, drug developers, and advocates united by a shared belief: patient insights are essential at every stage of our development, from early discovery through commercialization and beyond.
READ MORECrinetics Pharmaceuticals to Host R&D Day on June 26, 2025
Crinetics Pharmaceuticals will host an in-person and virtual R&D Day in New York on Thursday, June 26, 2025, from 9:00 AM to 12:00 PM ET.
READ MORECrinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 74,000 shares of its common stock and granted an aggregate of 48,850 restricted stock unit awards to 20 new non-executive employees.
READ MOREUnderstanding the Role of IGF-1 in Managing Acromegaly
Dr. Alan KrasnerChief Endocrinologist If you are living with acromegaly, you’ve likely heard your healthcare provider talk about "IGF-1" during your appointments. But what exactly is IGF-1, and why is it so important to understanding and managing your condition? IGF-1, short for Insulin-like Growth Factor-1, is a hormone produced primarily by the liver in response to growth hormone (GH).
READ MOREAcromegaly Awareness Day: Our Support to the Community Today and Beyond
Dana Pizzuti, M. D. Chief Medical and Development Officer Each year on November 1, the acromegaly community comes together to observe Acromegaly Awareness Day—an important moment in time to raise awareness of this rare endocrine disease and provide support for all those impacted by it.
READ MORECelebrating Women’s Leadership: Crinetics’ Commitment to Scientific and Strategic Excellence
Jacqui KirbyChief Corporate Affairs Officer As I reflect on Women’s History Month, I find myself reflecting on the inspiring leaders who have shaped the pharmaceutical industry through their vision and determination. Many of these leaders are celebrated scientists, researchers and physicians working to improve patient lives. As the newly appointed chief corporate affairs officer at Crinetics Pharmaceuticals, I find myself equally inspired by the remarkable female leaders in corporate affairs who have transformed how organizations articulate their vision, engage stakeholders and ultimately influence business performance.
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
